Capricor Therapeutics Ownership | Who Owns Capricor Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Capricor Therapeutics Ownership Summary


Capricor Therapeutics is owned by 29.93% institutional investors, 16.79% insiders, and 53.27% retail investors. Vanguard group is the largest institutional shareholder, holding 6.88% of CAPR shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.64% of its assets in Capricor Therapeutics shares.

CAPR Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCapricor Therapeutics29.93%16.79%53.27%
SectorHealthcare Stocks 218.58%11.00%-129.58%
IndustryBiotech Stocks 296.15%10.91%-207.06%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group2.28M6.88%$31.42M
State street2.21M6.67%$30.48M
Blackrock funding, inc. /de2.98M6.53%$29.63M
Blackrock1.63M5.19%$7.77M
Geode capital management879.47K2.66%$12.14M
Woodline partners lp629.93K1.90%$8.69M
Goldman sachs group294.77K0.89%$4.07M
Susquehanna group, llp281.30K0.85%$3.88M
Pier capital367.72K0.80%$3.65M
Black diamond financial277.74K0.61%$2.76M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Propel bio management70.00K0.84%$695.10K
Pier capital367.72K0.56%$3.65M
Black diamond financial277.74K0.43%$2.76M
Ellerson group inc /adv17.10K0.12%$169.80K
Woodline partners lp629.93K0.06%$8.69M
Sherbrooke park advisers10.47K0.05%$103.99K
Hbk sorce advisory127.63K0.03%$1.27M
Magnus financial group20.00K0.03%$276.00K
Jump financial232.54K0.03%$2.31M
Virtus investment advisers6.75K0.02%$66.99K

Top Buyers

HolderShares% AssetsChange
State street2.21M0.00%1.70M
Blackrock1.63M0.00%1.25M
Vanguard group2.28M0.00%700.24K
Woodline partners lp629.93K0.06%629.93K
Geode capital management879.47K0.00%241.28K

Top Sellers

HolderShares% AssetsChange
Farallon capital management41.00K0.00%-2.21M
Altium capital management lp---714.00K
Octagon capital advisors lp---450.00K
Ikarian capital---300.00K
Point72 asset management---250.20K

New Positions

HolderShares% AssetsChangeValue
Woodline partners lp629.93K0.06%629.93K$8.69M
National bank of canada /fi/168.70K0.00%168.70K$1.68M
Propel bio management70.00K0.84%70.00K$695.10K
Swiss national bank67.40K0.00%67.40K$930.12K
D. e. shaw53.73K0.00%53.73K$741.53K

Sold Out

HolderChange
True wealth design-5.00
Gamma investing-10.00
Parallel advisors-13.00
Northwestern mutual wealth management-19.00
Parkside financial bank & trust-40.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025132-7.04%13,682,657-27.15%291.77%63-24.10%4037.93%
Mar 31, 202510-92.48%930,147-94.63%20.08%7-92.39%2-86.67%
Dec 31, 202440-57.45%6,498,502-22.35%193.07%32-42.86%3-72.73%
Sep 30, 20249438.24%8,369,32730.24%256.02%5633.33%11-26.67%
Jun 30, 2024687.94%6,426,23433.35%208.30%42-1566.67%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.21M2.64%-26.63K
iShares Russell 2000 ETF908.35K1.99%-17.22K
Vanguard US Total Market Shares ETF872.18K1.91%-
SPDR® S&P Biotech ETF581.05K1.27%14.36K
Vanguard Institutional Extnd Mkt Idx Tr457.38K1.00%-200.35K
Fidelity Small Cap Index371.56K0.81%-
iShares Russell 2000 Growth ETF336.12K0.74%-
Fidelity Extended Market Index228.19K0.50%-596.00
State St Russell Sm/Mid Cp® Indx NL Cl C227.13K0.50%1.15K
State St Russell Sm/Mid Cp® Indx SL Cl I227.13K0.50%-

Recent Insider Transactions


DateNameRoleActivityValue
Sep 20, 2024Nippon Shinyaku Co Ltd-Buy$15.00M
Oct 12, 2023Musket David B-Buy$1.13K
Oct 10, 2023COLLIER EARL M JR-Buy$28.30K
Oct 09, 2023Musket David B-Buy$14.33K
Oct 06, 2023Auwaerter Paul Gisbert-Buy$14.20K

Insider Transactions Trends


DateBuySell
2025 Q1--
2024 Q4--
2024 Q31-
2024 Q2--
2024 Q1--

CAPR Ownership FAQ


Who Owns Capricor Therapeutics?

Capricor Therapeutics shareholders are primarily institutional investors at 29.93%, followed by 16.79% insiders and 53.28% retail investors. The average institutional ownership in Capricor Therapeutics's industry, Biotech Stocks , is 296.15%, which Capricor Therapeutics falls below.

Who owns the most shares of Capricor Therapeutics?

Capricor Therapeutics’s largest shareholders are Vanguard group (2.28M shares, 6.88%), State street (2.21M shares, 6.67%), and Blackrock funding, inc. /de (2.98M shares, 6.53%). Together, they hold 20.08% of Capricor Therapeutics’s total shares outstanding.

Does Blackrock own Capricor Therapeutics?

Yes, BlackRock owns 5.19% of Capricor Therapeutics, totaling 1.63M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 7.77M$. In the last quarter, BlackRock increased its holdings by 1.25M shares, a 326.62% change.

Who is Capricor Therapeutics’s biggest shareholder by percentage of total assets invested?

Propel bio management is Capricor Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.84% of its assets in 70K Capricor Therapeutics shares, valued at 695.1K$.

Who is the top mutual fund holder of Capricor Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Capricor Therapeutics shares, with 2.64% of its total shares outstanding invested in 1.21M Capricor Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools